Surgical Considerations for Immunotherapy in the Treatment of Malignant Glioma

Webinar Four

Release Date:  July 1, 2020, Expiration Date:  June 30, 2022

Learning Objectives:

  1. Participants will be able to describe the goals of surgery for gliomas.  
  2. Participants will be able to understand surgical options in the treatment of gliomas.  
  3. Participants will be able to describe how surgery may be combined with immunotherapy.    

Target Audience:

This lecture is attended for primary care physicians, specialty physicians, physician assistants and nurses.


The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 


The University of Florida College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Planning Committee Disclosure:

Conflict of interest information for the CME Advisory Committee members can be found on the following website:

Faculty Disclosure:

Dr. Rahman has disclosed that she has no relevant financial disclosures.  No one else in a position to control content has any financial relationships to disclose.

Bibliographic Sources:

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95 (2):190-198. doi:10.3171/jns.2001.95.2.0190 

Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115 (1):3-8. doi:10.3171/2011.2.JNS10998 

Rahman M, Abbatematteo J, De Leo EK, Kubilis PS, Vaziri S, Bova F, Sayour E, Mitchell D, Quinones-Hinojosa A (2017) The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. J Neurosurg 127 (1):123-131. doi:10.3171/2016.7.JNS16396 

Back to CME Series Main Page